Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00767806 · ClinicalTrials.gov registry record · Phase 3
A Study for Patient With Chronic Low Back Pain
A Phase 3 study, sponsored by Eli Lilly and Company.
- Completed
- Registry status
- Phase 3
- Development phase
- 401
- Enrollment target
NCT00767806 is a Phase 3 study that has completed, run by Eli Lilly and Company. The registered enrollment target is 401 participants.
The verdict
NCT00767806, a Phase 3 study, has completed, sponsored by Eli Lilly and Company.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 401 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if duloxetine reduces the severity of chronic low back pain.
Interventions
- DRUG Placebo
- DRUG Duloxetine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 401 participants |
| Start Date | 2008-09 |
| Est. Completion | 2009-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00767806
The ClinicalTrials.gov registry entry for NCT00767806 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 401 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eli Lilly and Company, which has 1,341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00767806 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00767806 about?
NCT00767806 is a clinical study titled "A Study for Patient With Chronic Low Back Pain". The purpose of this study is to determine if duloxetine reduces the severity of chronic low back pain.
What is the current status of trial NCT00767806?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 401 participants. The study started on 2008-09. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00767806?
The interventions under investigation include: Placebo (DRUG), Duloxetine (DRUG).
Who is sponsoring clinical trial NCT00767806?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.